RekrutujeFaza III
SABINE - The efficacy and Safety of delayed-release Budesonide in children with primary IgA nephropathy - a multicenter, interventional phase III, randomized, placebo-controlled…
Miasta: Białystok, Gdańsk, Kraków, Lublin i 4 inne miastaWiek: do 17.99 latSponsor: Medical University Of Warsaw
RekrutujeFaza III
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously…
Miasta: Bystra, Gdańsk, Kraków, Lublin i 7 innych miastWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza II/III
Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum
Miasta: Kraków, Poznań, WarszawaWiek: 6-18 latSponsor: Medical University of Warsaw
RekrutujeFaza IV
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Miasta: Katowice, Opole, Poznań, Rzeszów i 5 innych miastWiek: od 18 latSponsor: Alimentiv Inc.
RekrutujeFaza III
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Miasta: Tarnów, Warszawa, ŁódźWiek: do 17.99 latSponsor: Sanofi-Aventis Research & Development
RekrutujeFaza III
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Miasta: Białystok, Kraków, Poznań, WarszawaWiek: od 18 latSponsor: Pfizer Inc.
RekrutujeFaza I/II
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously…
Miasta: Gdańsk, Kraków, OlsztynWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza III
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Miasta: Gdańsk, Katowice, Kraków, Rzeszów i 4 inne miastaWiek: do 17.99 latSponsor: Takeda Development Center Americas Inc.